Tech Company Financing Transactions

Rapid Diagnostek Funding Round

TGAP Ventures, Capital Midwest Fund and NEW Capital Fund participated in a $4.6 million venture round for Rapid Diagnostek. The round was announced on 6/6/2012.

Transaction Overview

Company Name
Announced On
6/6/2012
Transaction Type
Venture Equity
Amount
$4,635,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
14505 21st Ave. N 212
Plymouth, MN 55447
USA
Email Address
Overview
Rapid Diagnostek is utilizing proprietary technology to develop a new generation of in vitro diagnostic tests through the use of our patented RFPS (radio frequency phase shift) detection technology and our disposable IntelliProbe Immunosensor (IPI).
Profile
Rapid Diagnostek LinkedIn Company Profile
Social Media
Rapid Diagnostek Company Twitter Account
Company News
Rapid Diagnostek News
Facebook
Rapid Diagnostek on Facebook
YouTube
Rapid Diagnostek on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Louis Pollock
  Louis Pollock LinkedIn Profile  Louis Pollock Twitter Account  Louis Pollock News  Louis Pollock on Facebook
VP - Engineering
James Webster
  James Webster LinkedIn Profile  James Webster Twitter Account  James Webster News  James Webster on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/6/2012: Identified venture capital transaction
Next: 6/6/2012: NetProspex venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary